#ExpertAnswers: Yuning Chen on Antibody Production
Yuning Chen discusses strategies involved in recombinant antibody production and introduces a novel antibody expression platform to facilitate antibody library generation.
Industry Insights with Yuning Chen on Recombinant Proteins
Yuning Chen discusses The “ProVir™” collection and the role of recombinant virus proteins in the development of infectious disease treatment regimes and vaccines.
#ExpertAnswers: Bin Xie on Drug Development for Immuno-Oncology
Bin Xie discusses the current immuno-oncology drug development landscape, different humanized mouse models available for drug testing, and the investigation of potential mechanisms via imaging mass cytometry.
Optimizing Cell Therapy Research Workflows
A 2-part mini series from STEMCELL Technologies highlighting optimized products, protocols, and workflows for cell therapy research.
Visualizing the Intracellular Immune Response to SARS-CoV-2 with Fast, High-Content Imaging
Experts discuss how automated microscopy and image analysis can quantify critical markers of infection and describe the insight provided by microscopy in the context of SARS-CoV-2 infection and inflammation.
Quick and Easy Isolation of T Cells and Other Immune Cells from Large-Volume Samples
Experts present a novel platform that enables efficient immune cell isolation from large-volume samples.
Optimizing CD34+ Cell Genome Editing for Efficiency and HSPC Maintenance
Experts provide tips and tricks to lock down effective genome editing conditions for CD34+ cells, methods to evaluate genome editing efficiency, and optimal culture conditions to maintain HSPC function and long-term editing effects.
Monitoring Cellular Immune Response in Real Time with Next Generation Immunoassays on the Ella Platform
Experts discuss the use of Simple Plex immunoassays on Ella to monitor the cellular immune response to SARS-CoV-2 in real time.
Recombinant Antibody Production: Current Methods and a Novel Antibody Generation Platform
Dr. Yuning Chen discusses strategies involved in recombinant antibody production and introduce a novel antibody expression platform to facilitate antibody library generation.
Current and Novel Immuno-Oncology Drug Evaluation Methods via Humanized Mouse Models
Dr. Bin Xie discusses the current immuno-oncology drug development landscape, different humanized mouse models available for drug testing, and the investigation of potential mechanisms via imaging mass cytometry.
Cutting Edge Conversations 2022
The Cutting Edge Conversations series offers a deep dive into specific research areas and focused insights regarding market-relevant processes from respected firms in the industry.
Cutting Edge Conversations: Addressing COVID-19 During Uncertainty
Hayley Crawford, PhD, and Carl Marci, MD, discuss how their specific industries have developed new innovations in response to the COVID-19 pandemic.
Cutting Edge Conversations: Biomarkers – Challenges and Opportunities
The 5th and final episode in the Cutting Edge Conversation series for 2021 features Dr. Morad Nakhleh, Natalie Smith, and Dr. Bhavika Patel as they discuss industry challenges and innovations surrounding biomarkers in life science research and precision medicine
Milestones and Recent Advances in HIV Research
In honor of World AIDS Day, InsideScientific has set out to provide information on the historical significance of HIV and AIDS, recent advances in anti-HIV therapy, and the impact that COVID-19 has had on HIV testing, diagnosis and treatment around the world.
#ExpertAnswers: Gwendalyn Randolph on Immunity
Gwendalyn Randolph discusses strategies that the intestine uses to limit the dissemination of inflammatory signals in the venous and lymphatic vasculature.
Cutting Edge Conversations: Innovative Approaches to Chemistry, Manufacturing and Controls
Episode 4 in the Cutting Edge Conversation series featured Dr. Mujeebur Rahuman, Dr. Holger von Moeller, and Dr. Fernando Huerta as they discuss about industry challenges and innovations surrounding Chemical, Manufacturing and Controls in the life sciences industry.
#ExpertAnswers: Jiahui Yang on Antibody Discovery Platforms
Dr. Jiahui Yang provides an overview of antibody discovery platforms and discusses how single B cell sorting can be used to generate functional monoclonal antibodies for a range of applications including disease diagnosis and therapeutics.
Cutting Edge Conversations 2021
Introducing Scientist.com's Fall 2021 Cutting Edge Conversations Series! This webinar series offers a deep dive into specific research areas and focused insights regarding market-relevant processes from respected firms in the industry. Each meeting will focus on a specific challenge and showcase the innovative approaches of different research organizations.
How Transformative Antibody Technology Can Improve Your Bioanalytical Assays
Dr. Royle discusses how the combination of antibody phage display and SpyTag technologies can generate critical antibody reagents with a difference.
#ExpertAnswers: Mariana Kaplan on Inflammation and Immunophysiology
Mariana Kaplan highlights the role of systemic autoimmunity in the development of vasculopathy and atherosclerosis and discussing potential strategies to prevent these complications.
#ExpertAnswers: Xuebin Qin on Inflammation and Immunophysiology
Dr. Xuebin Qin talks about his lab’s development and characterization of new models of SARS-CoV-2 and HIV, and how they use these models to study cardiovascular injury associated with infection.
Antibody Discovery Platforms to Support Functional Monoclonal Antibody Generation
Join Dr. Jiahui Yang as she provides an overview of antibody discovery platforms and discusses how single B cell sorting can be used to generate functional monoclonal antibodies for a range of applications.
#ExpertAnswers: Edward Bahnson on Light-sheet Fluorescence Microscopy and Vascular Injury
Edward Bahnson, PhD presents the development and validation of a methodological approach using light-sheet fluorescence microscopy (LSFM) for the imaging of preclinical models of vascular injury with a focus of minimizing analysis bias while increasing precision and reproducibility.
#ExpertAnswers: Marcela Maus on Inflammation and Immunophysiology
Dr. Marcela Maus discusses the components and technologies used in making a T cell product, important considerations for efficacy, and underlying mechanisms of toxicity and resistance.
